Trial CTRI/2022/04/042017
Publication Kulkarni P , Research Square, 2023
Primary outcome on the report: Anti-S IgG and neutralizing antibodies (nAbs)

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.